Notably, the recruitment mechanisms (CCL15 vs CXCL5/CXCL1/8) and effector molecules (VEGFC-dominant vs MMP9/VEGFA-cooperative) display cancer-type specificity, suggesting evolutionary selection for distinct molecular implementations of a conserved TANs-lymphatic metastasis principle. The gene discussed is CXCL1; the disease is cancer.